AMUNDI ASSET MANAGEMENT US, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$15,396,000
-15.0%
205,689
-1.8%
0.01%
-20.0%
Q4 2020$18,116,000
+32.8%
209,402
-6.2%
0.02%
+7.1%
Q3 2020$13,638,000
+76.5%
223,133
+20.1%
0.01%
+55.6%
Q2 2020$7,725,000
+41.0%
185,790
-2.6%
0.01%
-10.0%
Q1 2020$5,478,000
-64.6%
190,722
-11.0%
0.01%
-44.4%
Q4 2019$15,472,000
-38.0%
214,316
+20.4%
0.02%
-51.4%
Q3 2019$24,970,000
-28.8%
177,982
-7.0%
0.04%
+27.6%
Q2 2019$35,054,000
+61.5%
191,457
+40.3%
0.03%
-6.5%
Q1 2019$21,704,000
+133.6%
136,459
+40.7%
0.03%
+244.4%
Q4 2018$9,292,000
-31.5%
97,012
+1.0%
0.01%
-50.0%
Q3 2018$13,573,000
-16.6%
96,085
-7.5%
0.02%
-21.7%
Q2 2018$16,265,000
-2.8%
103,907
-0.0%
0.02%
-14.8%
Q1 2018$16,741,000
-16.0%
103,937
-14.1%
0.03%
-12.9%
Q4 2017$19,931,000
+76.6%
121,008
-33.2%
0.03%
-13.9%
Q3 2017$11,284,000
-10.6%
181,128
+14.3%
0.04%
-12.2%
Q2 2017$12,616,000
+154.2%
158,418
+126.9%
0.04%
+141.2%
Q1 2017$4,963,00069,8330.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders